Corient Private Wealth LLC Sells 598 Shares of U.S. Physical Therapy, Inc. (NYSE:USPH)

Corient Private Wealth LLC decreased its holdings in shares of U.S. Physical Therapy, Inc. (NYSE:USPH) by 13.3% during the fourth quarter, HoldingsChannel reports. The institutional investor owned 3,896 shares of the company’s stock after selling 598 shares during the period. Corient Private Wealth LLC’s holdings in U.S. Physical Therapy were worth $346,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors have also recently modified their holdings of the company. Copeland Capital Management LLC grew its stake in U.S. Physical Therapy by 9.5% in the 4th quarter. Copeland Capital Management LLC now owns 839,356 shares of the company’s stock worth $74,459,000 after acquiring an additional 72,715 shares in the last quarter. State Street Corp grew its stake in U.S. Physical Therapy by 17.5% in the third quarter. State Street Corp now owns 667,868 shares of the company’s stock worth $56,522,000 after purchasing an additional 99,244 shares in the last quarter. Southernsun Asset Management LLC increased its holdings in U.S. Physical Therapy by 10.5% during the 3rd quarter. Southernsun Asset Management LLC now owns 547,111 shares of the company’s stock worth $46,302,000 after purchasing an additional 52,062 shares during the period. Geode Capital Management LLC raised its position in U.S. Physical Therapy by 1.3% during the 3rd quarter. Geode Capital Management LLC now owns 343,073 shares of the company’s stock valued at $29,040,000 after purchasing an additional 4,477 shares in the last quarter. Finally, Bahl & Gaynor Inc. lifted its holdings in shares of U.S. Physical Therapy by 135.4% in the 4th quarter. Bahl & Gaynor Inc. now owns 260,125 shares of the company’s stock worth $23,076,000 after buying an additional 149,622 shares during the period.

Insider Activity

In other U.S. Physical Therapy news, COO Graham D. Reeve sold 1,730 shares of U.S. Physical Therapy stock in a transaction dated Friday, March 7th. The stock was sold at an average price of $82.11, for a total transaction of $142,050.30. Following the completion of the sale, the chief operating officer now owns 7,168 shares of the company’s stock, valued at approximately $588,564.48. The trade was a 19.44 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. Corporate insiders own 1.70% of the company’s stock.

Analysts Set New Price Targets

Several brokerages have recently commented on USPH. William Blair restated a “market perform” rating on shares of U.S. Physical Therapy in a research note on Thursday, February 27th. StockNews.com lowered shares of U.S. Physical Therapy from a “hold” rating to a “sell” rating in a report on Friday, February 28th. Bank of America upgraded shares of U.S. Physical Therapy from a “neutral” rating to a “buy” rating and increased their price objective for the company from $100.00 to $115.00 in a research note on Monday, December 16th. Citizens Jmp raised shares of U.S. Physical Therapy to a “strong-buy” rating in a report on Monday, December 16th. Finally, JMP Securities started coverage on U.S. Physical Therapy in a report on Monday, December 16th. They set an “outperform” rating and a $113.00 target price for the company. One investment analyst has rated the stock with a sell rating, one has given a hold rating, four have assigned a buy rating and one has issued a strong buy rating to the company. According to MarketBeat.com, U.S. Physical Therapy currently has an average rating of “Moderate Buy” and a consensus target price of $109.00.

U.S. Physical Therapy Trading Down 1.6 %

NYSE USPH opened at $71.92 on Monday. U.S. Physical Therapy, Inc. has a 52 week low of $71.11 and a 52 week high of $113.63. The company has a 50 day moving average price of $83.25 and a 200 day moving average price of $86.59. The company has a quick ratio of 1.78, a current ratio of 1.78 and a debt-to-equity ratio of 0.27. The firm has a market cap of $1.09 billion, a PE ratio of 76.51, a price-to-earnings-growth ratio of 3.54 and a beta of 1.51.

U.S. Physical Therapy (NYSE:USPH) last issued its quarterly earnings data on Wednesday, February 26th. The company reported $0.65 EPS for the quarter, missing the consensus estimate of $0.69 by ($0.04). U.S. Physical Therapy had a net margin of 3.54% and a return on equity of 8.11%. The business had revenue of $180.45 million for the quarter, compared to analysts’ expectations of $173.10 million. As a group, sell-side analysts forecast that U.S. Physical Therapy, Inc. will post 2.67 EPS for the current fiscal year.

U.S. Physical Therapy Increases Dividend

The firm also recently declared a quarterly dividend, which will be paid on Friday, April 11th. Stockholders of record on Friday, March 14th will be paid a dividend of $0.45 per share. This is a positive change from U.S. Physical Therapy’s previous quarterly dividend of $0.44. The ex-dividend date of this dividend is Friday, March 14th. This represents a $1.80 dividend on an annualized basis and a dividend yield of 2.50%. U.S. Physical Therapy’s payout ratio is presently 97.83%.

About U.S. Physical Therapy

U.S. Physical Therapy, Inc operates outpatient physical therapy clinics. The company operates through Physical Therapy Operations and Industrial Injury Prevention Services segments. The company provides pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries.